• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23734 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     NIHR Horizon Scanning Centre (NIHR HSC) SAR-302503 for myelofibrosis – first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) SAR236553/REGN727 for the reduction of elevated total cholesterol and low density lipoprotein cholesterol
2008     NIHR Horizon Scanning Centre (NIHR HSC) Saredutant (SR-48968) for depression and anxiety
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sarilumab for moderate to severe active rheumatoid arthritis
2017     National Institute for Health and Care Excellence (NICE) Sarilumab for moderate to severe rheumatoid arthritis. NICE technology appraisal guidance 485
2021     European Network for Health Technology Assessment (EUnetHTA) Sarilumab for the treatment of COVID-19
2022     WorkSafeBC Satir brief transformational therapy as treatment for trauma-related disorders including PTSD
2005     NIHR Health Technology Assessment programme Satisfaction in Life for Children With Own Report Measures (SILCWORM)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sativex for adults experiencing pain from cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sativex for spasticity in multiple sclerosis
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Sativex for the management of multiple sclerosis symptoms
2024     National Institute for Health and Care Excellence (NICE) Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal). NICE technology appraisal guidance 960
2006     NIHR Horizon Scanning Centre (NIHR HSC) Satraplatin for second-line hormone-refractory prostate cancer: horizon scanning technology briefing
2004     NIHR Horizon Scanning Centre (NIHR HSC) Satraplatin for second-line treatment of hormone-refractory prostate cancer - horizon scanning review
2009     HAYES, Inc. Saw palmetto for benign prostatic hyperplasia
2008     NIHR Horizon Scanning Centre (NIHR HSC) Saxagliptin (BMS 477118) for type 2 diabetes
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Saxagliptin (Onglyza - Bristol-Myers Squibb/AstraZeneca Canada Inc.) indication: type 2 diabetes mellitus
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Saxagliptin + metformin (Komboglyze — AstraZeneca) indication: type 2 diabetes mellitus
2008     Adelaide Health Technology Assessment (AHTA) Scalable Medical Alert Response Technology (SMART) for monitoring emergency department patients
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Scale and polish for chronic periodontal disease
2013     Penn Medicine Center for Evidence-based Practice (CEP) Scales for assessing inpatients' risk of accidental falls
2018     Penn Medicine Center for Evidence-based Practice (CEP) Scales for Assessing Patients Receiving Moderate Sedation
2005     The Swedish Council on Health Technology Assessment (SBU) Scalp cooling to prevent chemotherapy-induced hair loss - early assessment briefs (Alert)
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Scalpel safety in the operative setting: a systematic review
1996     Alberta Heritage Foundation for Medical Research (AHFMR) Scanning laser ophthalmoscope for diagnosis and monitoring of glaucoma
2002     HAYES, Inc. Scanning laser polarimetry for detection and monitoring of glaucoma
2008     HAYES, Inc. Scanning laser polarimetry for detection and monitoring of glaucoma
2022     Agency for Healthcare Research and Quality (AHRQ) Schedule of visits and televisits for routine antenatal care
1993     Danish Institute for Health Services Research (DSI) Schizophrenia, Consensus statement
2021     NIHR Public Health Research (PHR) programme School-based interventions to prevent anxiety, depression and conduct disorder in children and young people: a systematic review and network meta-analysis
2010     NIHR Health Technology Assessment programme School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities
1998     Australian Health Technology Advisory Committee (AHTAC) Scientific literature review of lung transplantation
2010     Adelaide Health Technology Assessment (AHTA) Scintimammograms or breast-specific gamma imaging (BSGI) for the evaluation of disease spread in women diagnosed with breast cancer
2003     Medical Advisory Secretariat (MAS) Scintimammography
2007     Medical Advisory Secretariat (MAS) Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis
2004     National Institute for Health and Care Excellence (NICE) Scleral expansion surgery for presbyopia. NICE interventional procedures guidance 70
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Scleral support surgery for pathologic myopia
2005     HAYES, Inc. Sclerotherapy for esophageal varices
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Sclerotherapy for leg varicose veins
2000     HAYES, Inc. Sclerotherapy for symptomatic varicose veins
2004     HAYES, Inc. Sclerotherapy for symptomatic varicose veins
2003     Alberta Heritage Foundation for Medical Research (AHFMR) Sclerotherapy for varicose veins of the legs
2000     HAYES, Inc. Sclerotherapy, joint and ligamentous injections
2000     HAYES, Inc. Sclerotherapy, oesophageal varices
2004     Adelaide Health Technology Assessment (AHTA) ScopeGuide (TM): magnetic endoscopic imaging of the colon for patients requiring colonoscopy
2020     Health Information and Quality Authority (HIQA) Scoping evidence summary for surgical outcomes in patients with COVID-19
2020     Health Information and Quality Authority (HIQA) Scoping report: universal influenza vaccination in children
1999     University of York Scoping review of literature on the health and care of mentally disordered offenders
2004     University of York Scoping review of sabotage and/or tampering in the NHS
2001     University of York Scoping review of the effectiveness of mental health services
2003     NIHR Health Technology Assessment programme Scoping study on the assessment of the star ratings
2002     Centre for Clinical Effectiveness (CCE) Scoring systems for assessing postoperative risk in colorectal surgery
2005     NIHR Health Technology Assessment programme Scottish trial of arthroplasty or reduction for subcapital fractures (STARS)- primary research
2012     NIHR Horizon Scanning Centre (NIHR HSC) SCOUT DS® and Diab-spot for type 2 diabetes screening
2016     HAYES, Inc. Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of chronic pain related to cancer or cancer treatment
2016     HAYES, Inc. Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of pain not related to cancer
2008     Health Council of the Netherlands Gezondheidsraad (GR) Screening : between hope and hype
2010     Agency for Healthcare Research and Quality (AHRQ) Screening adults for bladder cancer: update of the 2004 evidence review for the U.S. Preventive Services Task Force
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and assessment tools for patients with chronic disease in therapeutic exercise program: a review of the clinical evidence and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Screening and diagnosing gestational diabetes mellitus
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2005     Agency for Healthcare Research and Quality (AHRQ) Screening and interventions for childhood overweight: evidence synthesis
2003     Agency for Healthcare Research and Quality (AHRQ) Screening and interventions for overweight and obesity in adults
2013     Health Quality Ontario (HQO) Screening and management of depression for adults with chronic diseases: an evidence-based analysis
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Screening and testing for COVID-19 before surgery
2008     Agency for Healthcare Research and Quality (AHRQ) Screening and treatment for bacterial vaginosis in pregnancy: systematic review to update the 2001 U.S. Preventive Services Task Force recommendation
1999     Health Council of the Netherlands Gezondheidsraad (GR) Screening and treatment of adolescents with schizophrenia
2005     Adelaide Health Technology Assessment (AHTA) Screening and treatment of gestational diabetes mellitus
2011     Agency for Healthcare Research and Quality (AHRQ) Screening and treatment of subclinical hypothyroidism or hyperthyroidism
2004     VA Technology Assessment Program (VATAP) Screening colonoscopy by mid-level practitioners
2008     The Swedish Council on Health Technology Assessment (SBU) Screening for abdominal aortic aneurysm
2004     Center for Medical Technology Assessment (CMT) Screening for abdominal aortic aneurysm - a health economic assessment
2008     The Swedish Council on Health Technology Assessment (SBU) Screening for abdominal aortic aneurysm [update]
2003     The Swedish Council on Health Technology Assessment (SBU) Screening for abdominal aortic aneurysms - early assessment briefs (Alert)
2007     Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic carotid artery stenosis
2014     Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
2003     Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic coronary artery disease: a systematic review for the U.S. Preventive Services Task Force
2001     Agency for Healthcare Research and Quality (AHRQ) Screening for bacterial vaginosis in pregnancy
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for bilirubin encephalopathy
2004     Agency for Healthcare Research and Quality (AHRQ) Screening for bladder cancer
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for breast cancer
1993     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Screening for breast cancer in women aged 40-49 years
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force
1995     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Screening for cancer of the prostate: an evaluation of benefits, unwanted health effects and costs - nonsystematic review
2002     Agency for Healthcare Research and Quality (AHRQ) Screening for cervical cancer
2002     Health Technology Advisory Committee (HTAC) Screening for cervical cancer: recent advances
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for child and adolescent depression in primary care settings: a systematic evidence review for the U.S. Preventive Services Task Force
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for chlamydia trachomatis and neisseria gonorrhoeae during pregnancy: a health technology assessment
2001     Agency for Healthcare Research and Quality (AHRQ) Screening for chlamydial infection
2007     Agency for Healthcare Research and Quality (AHRQ) Screening for chlamydial infection: a focused evidence update for the U.S. Preventive Services Task Force
2008     Agency for Healthcare Research and Quality (AHRQ) Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force
2008     Agency for Healthcare Research and Quality (AHRQ) Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force.
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2001     Norwegian Knowledge Centre for the Health Services (NOKC) Screening for colorectal cancer
2002     The Swedish Council on Health Technology Assessment (SBU) Screening for colorectal cancer - early assessment briefs (ALERT)